Bank of New York Mellon Corp - MYOVANT SCIENCES LTD ownership

MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 36 filers reported holding MYOVANT SCIENCES LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of MYOVANT SCIENCES LTD
ValueSharesWeighting
Q4 2022$1,547,908
+230.0%
57,415
+119.8%
0.00%
Q3 2022$469,000
+43.4%
26,121
-0.6%
0.00%
Q2 2022$327,000
-7.6%
26,276
-1.2%
0.00%
Q1 2022$354,000
-14.5%
26,5830.0%0.00%
Q4 2021$414,000
-30.7%
26,5830.0%0.00%
Q3 2021$597,000
+20.4%
26,583
+22.0%
0.00%
Q2 2021$496,000
-41.4%
21,783
-47.0%
0.00%
Q1 2021$846,000
+27.2%
41,125
+70.7%
0.00%
Q4 2020$665,000
+101.5%
24,094
+2.6%
0.00%
Q3 2020$330,000
-46.7%
23,479
-21.8%
0.00%
Q2 2020$619,000
+172.7%
30,040
-0.0%
0.00%
Q1 2020$227,000
-51.3%
30,041
+0.0%
0.00%
Q4 2019$466,000
-79.0%
30,040
-93.0%
0.00%
-100.0%
Q3 2019$2,224,000
-40.0%
427,557
+4.4%
0.00%0.0%
Q2 2019$3,706,000
-62.7%
409,507
-1.7%
0.00%
-66.7%
Q1 2019$9,944,000
+64.1%
416,563
+12.8%
0.00%
+50.0%
Q4 2018$6,060,000
+1823.8%
369,320
+3012.4%
0.00%
Q3 2018$315,000
+16.2%
11,8660.0%0.00%
Q2 2018$271,000
+7.5%
11,8660.0%0.00%
Q1 2018$252,000
+57.5%
11,866
-6.5%
0.00%
Q4 2017$160,000
-13.0%
12,686
+6.9%
0.00%
Q3 2017$184,000
+32.4%
11,8660.0%0.00%
Q2 2017$139,000
-50.2%
11,866
-50.1%
0.00%
Q1 2017$279,000
+28.6%
23,784
+36.3%
0.00%
Q4 2016$217,00017,4540.00%
Other shareholders
MYOVANT SCIENCES LTD shareholders Q3 2018
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 142,065$2,924,0004.61%
Tri Locum Partners LP 321,101$6,608,0001.64%
PFM Health Sciences, LP 2,054,928$42,290,0001.29%
Bellevue Group AG 5,194,039$106,893,0001.13%
Pier Capital, LLC 554,779$11,417,0001.08%
Opaleye Management Inc. 249,800$5,141,0000.76%
Evolution Wealth Advisors, LLC 140,227$2,886,0000.64%
Hennion & Walsh Asset Management, Inc. 399,330$8,218,0000.49%
Cormorant Asset Management, LP 1,000,000$20,580,0000.46%
Integral Health Asset Management, LLC 65,000$1,338,0000.38%
View complete list of MYOVANT SCIENCES LTD shareholders